Sanofi (SNY)
39.56
+0.05
(+0.13%)
USD |
NASDAQ |
Oct 06, 16:00
39.80
+0.24
(+0.61%)
After-Hours: 06:01
Sanofi Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2013 | 57.66% |
| June 30, 2013 | |
| December 31, 2012 | |
| June 30, 2012 | 59.70% |
| December 31, 2011 | |
| June 30, 2011 | 54.31% |
| December 31, 2010 | 57.21% |
| June 30, 2010 |
| Date | Value |
|---|---|
| December 31, 2009 | 58.12% |
| June 30, 2009 | |
| December 31, 2008 | |
| June 30, 2008 | |
| December 31, 2007 | |
| June 30, 2007 | |
| December 31, 2006 | |
| June 30, 2006 | 45.40% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 76.09% |
| GSK Plc | 75.05% |
| Johnson & Johnson | 68.73% |
| Eli Lilly & Co. | 85.78% |
| Merck & Co., Inc. | 71.51% |